Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spinopelvic challenges in primary total hip arthroplasty. | EFORT Open Rev | 2023 | 37158334 | PubTator, text mining | PubMed |
| Use of whole-exome sequencing to identify novel monogenic gene mutations and genotype-phenotype correlations in Chinese Han children with urolithiasis. | Front Genet | 2023 | 37144129 | PubTator, text mining | PubMed |
| Unusual cause of cerebral calcifications in an 8-year-old girl. | Clin Case Rep | 2023 | 37143464 | PubTator, text mining | PubMed |
| Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients. | Front Genet | 2023 | 37139236 | PubTator, text mining | PubMed |
| iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function. | J Clin Invest | 2023 | 37115691 | PubTator, text mining | PubMed |
| Medical students' perceptions of the educational environment in a private medical school in Southwest Nigeria. | J Educ Health Promot | 2023 | 37113428 | PubTator, text mining | PubMed |
| Substantial Copper (Cu2+) Uptake by Metakaolin-Based Geopolymer and Its Resistance to Acid Leaching and Ion Exchange. | Polymers (Basel) | 2023 | 37112118 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses. | Int J Mol Sci | 2023 | 37108625 | PubTator, text mining | PubMed |
| Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family. | Genes (Basel) | 2023 | 37107689 | PubTator, text mining | PubMed |
| Pediatric chronic myeloid leukemia in myeloid blast crisis. | Autops Case Rep | 2023 | 37101551 | PubTator, text mining | PubMed |
| Identification of key biomarkers of the glomerulus in focal segmental glomerulosclerosis and their relationship with immune cell infiltration based on WGCNA and the LASSO algorithm. | Ren Fail | 2023 | 37096442 | PubTator, text mining | PubMed |
| Standardized Measures Used Regularly by Speech-Language Pathologists when Assessing the Language Abilities of School-Aged Children: A Survey. | Folia Phoniatr Logop | 2023 | 37094559 | PubTator, text mining | PubMed |
| Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma. | J Exp Clin Cancer Res | 2023 | 37069683 | PubTator, text mining | PubMed |
| Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US survey. | Urolithiasis | 2023 | 37067624 | PubTator, text mining | PubMed |
| Gly-Pro-Val-Gly-Pro-Ser Peptide Fish Collagen Improves Skin Moisture and Wrinkles with Ameliorated the Oxidative Stress and Pro-inflammatory Factors in Skin Photoaging Mimic Models. | Prev Nutr Food Sci | 2023 | 37066027 | PubTator, text mining | PubMed |
| Structural insights into the substrate recognition of serine palmitoyltransferase from Sphingobacterium multivorum. | J Biol Chem | 2023 | 37030501 | PubTator, text mining | PubMed |
| Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1. | Front Pediatr | 2023 | 37009285 | PubTator, text mining | PubMed |
| Drought stress in 'Shine Muscat' grapevine: Consequences and a novel mitigation strategy-5-aminolevulinic acid. | Front Plant Sci | 2023 | 37008472 | PubTator, text mining | PubMed |
| Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance. | Front Oncol | 2023 | 37007090 | PubTator, text mining | PubMed |
| ORMDL in metabolic health and disease. | Pharmacol Ther | 2023 | 37003301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=23